BPC-157· 10mg
Body Protection Compound. The default systemic-repair peptide.
Individual
$68.40
label.overview
15-amino-acid fragment from gastric juice BPC. Promotes angiogenesis at injury sites and accelerates tendon-to-bone healing.
BPC-157 is a partial sequence of body protection compound. It upregulates VEGFR2 and promotes microvascular formation around damaged tissue.
Mechanism
VEGFR2 upregulation; nitric oxide pathway modulation.
Researcher notes
- • 250 mcg subcutaneous near the area of interest, 1–2× daily.
- • Loading phase: 2–4 weeks daily; maintenance: 2–3× weekly.
- • Rotate injection sites.
Mechanism
VEGFR2 upregulation; nitric oxide pathway modulation.
Half-life
~4 hours
Reconstitution
Add 2 mL bacteriostatic water to the 10 mg vial. Each 0.05 mL = 250 mcg.
Storage
Lyophilized: room temp. Reconstituted: 2–8 °C, use within 30 days.
Reconstitution & general research dosing
- Reconstitution
- 2 mL bacteriostatic water into a 10 mg vial → 5 mg/mL (each 0.05 mL = 250 mcg).
- Typical research dose
- Reference 250–500 mcg per administration.
- Frequency
- 1–2× daily, subcutaneous — commonly placed near the site of interest in research models.
- Vial duration
- A 10 mg vial covers ~20 days at 500 mcg/day and ~10 days at 1000 mcg/day (2× 500 mcg). At 250 mcg/day the raw math reaches ~40 days, exceeding the 30-day reconstituted window — reconstitute the vial in halves (5 mg each).
- Storage
- Refrigerate 2–8 °C; use within 30 days reconstituted.